Free tool
Stocks above their 200-day average
We cover 27 companies trading above their own 200-day average. The median market value in the group is $1.20B. Across the group, the median move over the past trading day is 0.00%. 100% of the 27 with a 200-day average trade above it. Price change over the past year runs from −32.6% to +84.1% across the middle 80 percent of the group, with a median of +2.9%.
Other lists in this group
Table
27 of 10,735 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return | Next report |
|---|---|---|---|---|---|---|
| MDT | Medtronic plc | $92.02 | +5.92% | −3.41% | +2.29% | Sep 1, 2026 |
| 2M6.DE | Medtronic plc | 78.54 EUR | +1.19% | −2.78% | +2.65% | Sep 1, 2026 |
| HQY | HealthEquity, Inc. | $104.42 | +3.14% | +14.66% | +18.69% | Aug 27, 2026 |
| RHC.AX | Ramsay Health Care Limited | 50.09 AUD | +13.17% | +46.21% | +50.11% | Aug 27, 2026 |
| SECT-B.ST | Sectra AB (publ) | 276.20 SEK | −2.47% | +15.28% | −17.02% | Sep 4, 2026 |
| MSB.AX | Mesoblast Limited | 2.45 AUD | +19.85% | −11.73% | +1.03% | Aug 27, 2026 |
| MESO | Mesoblast Limited | $16.84 | +16.54% | −7.27% | +4.47% | Aug 27, 2026 |
| EKTA-B.ST | Elekta AB (publ) | 56.05 SEK | +14.95% | +0.87% | +26.10% | Aug 27, 2026 |
| KMTS | Kestra Medical Technologies, Ltd. | $26.57 | +11.36% | +8.94% | +47.61% | Sep 14, 2026 |
| INNV | InnovAge Holding Corp. | $11.04 | −6.52% | +112.72% | +178.79% | Sep 8, 2026 |
| 9627.T | Ain Holdings Inc. | 6,142.00 JPY | −2.57% | −5.73% | +2.85% | Sep 14, 2026 |
| CHEMM.CO | ChemoMetec A/S | 496.80 DKK | +15.59% | −26.35% | −3.94% | Sep 10, 2026 |
| SPI.L | Spire Healthcare Group plc | 237.00 GBP | +1.28% | +40.25% | +7.25% | Sep 9, 2026 |
| CVSG.L | CVS Group plc | 1,296.00 GBP | +3.27% | +1.73% | +2.05% | Sep 24, 2026 |
| GXI.DE | Gerresheimer AG | 25.58 EUR | −9.23% | −7.99% | −39.73% | Aug 27, 2026 |
| RZLT | Rezolute, Inc. | $5.04 | +2.44% | +132.79% | −30.00% | Sep 16, 2026 |
| BNTC | Benitec Biopharma Inc. | $12.88 | +8.33% | +2.34% | +0.16% | Sep 22, 2026 |
| CRNA.OL | Circio Holding ASA | 11.92 NOK | +37.80% | +877.05% | +1733.85% | Aug 31, 2026 |
| TRMED.OL | Thor Medical ASA | 6.76 NOK | +51.91% | +34.93% | +135.13% | Aug 28, 2026 |
| IPHA | Innate Pharma S.A. | $2.16 | +28.57% | +18.68% | +2.86% | Sep 17, 2026 |
| IPH.PA | Innate Pharma S.A. | 1.88 EUR | +19.01% | +16.21% | +1.19% | Sep 17, 2026 |
| HITI | High Tide Inc. | $2.52 | +22.33% | −10.00% | −30.00% | Sep 14, 2026 |
| PDEX | Pro-Dex, Inc. | $63.84 | +13.31% | +69.25% | +40.31% | Aug 27, 2026 |
| ANIX | Anixa Biosciences, Inc. | $3.61 | +2.41% | +14.08% | +22.20% | Sep 9, 2026 |
| ONCIN.OL | Oncoinvent ASA | 85.00 NOK | −2.07% | +80.85% | +10.90% | Aug 27, 2026 |
| INTEG-B.ST | Integrum AB (publ) | 8.66 SEK | −0.92% | −16.73% | −79.55% | Sep 3, 2026 |
| INM | InMed Pharmaceuticals Inc. | $1.43 | −14.37% | +27.68% | −36.44% | Sep 23, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.